Abstract
Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.
| Translated title of the contribution | Use of Anti-IL-20 antibody for treating stroke |
|---|---|
| Original language | English |
| Patent number | 8012478 |
| Publication status | Published - 2010 Apr 8 |
